6 recruiting. 6 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 6 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Encephalomyelitis: new trials by email Literature Review of Encephalomyelitis trials Research Report on Encephalomyelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Rituximab(Genetical Recombination), Placebo - Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | Phase 2 | Recruiting | National Center of Neurology and Psychiatry, Japan | 30 | 2025-04-09 | 2025-04-30 |
| RCT of Efficacy and Safety of CP003 on CFS/ME or Post COVID-19 Fatigue LingZhi capsule - Chronic Fatigue Syndrome (CFS), Post-COVID ME/CFS | Phase 2 / Phase 3 | Recruiting | The University of Hong Kong | 130 | 2025-01-02 | 2026-09-21 |
| Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Lumbrokinase - Long Covid, Post-treatment Lyme Disease Syndrome | Phase 1 / Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 120 | 2024-10-09 | 2026-03-13 |
| LIFT: Life Improvement Trial Pyridostigmine, Low-Dose Naltrexone, Placebo - ME/CFS, Long COVID | Phase 2 | Recruiting | Brigham and Women's Hospital | 160 | 2024-09-10 | 2026-10-15 |
| The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Floradapt Intensive GI, Placebo - ME/CFS, IBS - Irritable Bowel Syndrome | Phase 2 | Recruiting | Nova Southeastern University | 100 | 2022-12-20 | 2025-03-04 |
| Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED], placebo - Hypogonadism, Male, Fatigue Syndrome, Chronic | Phase 2 | Recruiting | Seattle Institute for Biomedical and Clinical Research | 240 | 2021-03-22 | 2026-06-22 |
Fatigue Syndrome, Chronic (6) · Post-Acute COVID-19 Syndrome (2) · Cognitive Dysfunction (1) · Eunuchism (1) · Hypogonadism (1) · Irritable Bowel Syndrome (1) · Lyme Disease (1) · Orthostatic Intolerance (1) · Post-Lyme Disease Syndrome (1)
Chronic Disease (6) · Disease Attributes (6) · Muscular Diseases (6) · Musculoskeletal Diseases (6) · Nervous System Diseases (6) · Neuroinflammatory Diseases (6) · Neuromuscular Diseases (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · COVID-19 (2) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2)
Drug Evaluation (1) · Naltrexone (1) · Pyridostigmine Bromide (1) · lumbrokinase (1) · testosterone undecanoate (1)
Brigham and Women's Hospital (1) · Icahn School of Medicine at Mount Sinai (1) · National Center of Neurology and Psychiatry, Japan (1) · Nova Southeastern University (1) · Seattle Institute for Biomedical and Clinical Research (1) · The University of Hong Kong (1)
United States (4) · Hong Kong (1) · Japan (1)
David Putrino, PhD, PT (1) · David Systrom, MD (1) · Jose M Garcia, MD, PhD (1) · Nancy Klimas, MD (1) · Tomoko Okamoto, MD (1)